Date published: 2026-4-13

1-800-457-3801

SCBT Portrait Logo
Seach Input

Aurora Inhibitors

Aurora inhibitors constitute a distinct class of chemical compounds that primarily target a family of serine/threonine protein kinases known as Aurora kinases. These kinases play pivotal roles in orchestrating various stages of cell division, including centrosome maturation, spindle assembly, chromosome segregation, and cytokinesis. The Aurora kinase family comprises three major members: Aurora A, Aurora B, and Aurora C. Aurora A is primarily associated with centrosome maturation and separation during early mitosis, while Aurora B is involved in regulating chromosome segregation and cytokinesis during late mitosis. Aurora C, while less studied, also contributes to cell division processes. The underlying mechanism of Aurora inhibitors centers around disrupting the finely tuned phosphorylation events orchestrated by Aurora kinases. These compounds are typically small molecules that interfere with the kinase's active site by competitively binding to the ATP-binding pocket. By doing so, Aurora inhibitors impede the kinase's ability to phosphorylate its substrates, thereby inducing defects in cell division. Specifically, inhibition of Aurora A often leads to defects in centrosome maturation and separation, causing aberrant spindle formation and aneuploidy. Likewise, inhibition of Aurora B affects chromosome alignment and cytokinesis, leading to the accumulation of multinucleated cells. Aurora inhibitors exhibit varying degrees of selectivity towards different Aurora kinase isoforms, with some compounds preferentially targeting Aurora A, Aurora B, or both. Additionally, due to the crucial role of Aurora kinases in cell division, these inhibitors have garnered significant attention in cancer research, as unchecked cell division is a hallmark of cancer. However, their applications extend beyond oncology, as they also offer insights into fundamental cell cycle processes. In conclusion, Aurora inhibitors constitute a pharmacologically intriguing class of compounds that provide researchers with valuable tools to dissect the intricate mechanisms governing cell division and mitosis, shedding light on both physiological and pathological aspects of cellular behavior.
Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

AZD1152-HQPA

722544-51-6sc-265334
10 mg
$375.00
(0)

AZD1152-HQPA is characterized by its selective inhibition of Aurora kinases, which play a crucial role in cell cycle regulation. This compound disrupts the phosphorylation of key substrates, leading to mitotic arrest and subsequent apoptosis in rapidly dividing cells. Its unique binding affinity to the ATP-binding site of Aurora kinases enhances its potency, while its structural features facilitate effective interactions with the kinase domain, influencing downstream signaling pathways and cellular dynamics.

MLN8237

1028486-01-2sc-394162
5 mg
$220.00
(0)

Alisertib is a selective inhibitor of Aurora A kinase. It disrupts the phosphorylation of Aurora A and prevents its activation, leading to cell cycle arrest and apoptosis in cancer cells.

AT9283

896466-04-9sc-364738
sc-364738A
2 mg
10 mg
$180.00
$400.00
(0)

AT9283 functions as a potent Aurora kinase inhibitor, exhibiting a unique ability to disrupt the ATP-binding pocket through specific molecular interactions. Its structural conformation facilitates selective binding, leading to the inhibition of kinase activity and subsequent alterations in cell cycle regulation. The compound showcases distinctive reaction kinetics, characterized by a rapid onset of action and sustained engagement, effectively modulating mitotic processes and influencing cellular proliferation dynamics.

MLN 8054

869363-13-3sc-484828
5 mg
$398.00
(0)

MLN8054 inhibits Aurora A by competing with ATP for binding to the kinase's active site. This prevents phosphorylation of Aurora A substrates, resulting in cell cycle disruption and apoptosis in cancer cells.

Tozasertib

639089-54-6sc-358750
sc-358750A
25 mg
50 mg
$62.00
$87.00
4
(1)

VX-680 (Tozasertib) inhibits Aurora A by binding to its ATP-binding pocket. This interference disrupts Aurora A's function in cell cycle progression, leading to cell division defects and eventual cell death.

ZM-447439

331771-20-1sc-200696
sc-200696A
1 mg
10 mg
$153.00
$356.00
15
(1)

ZM447439 inhibits Aurora A kinase and other kinases involved in cell cycle regulation. It disrupts centrosome separation and spindle assembly, leading to mitotic arrest and cell death.